Evidence map›Paper›PMID 42266963›Full record

ArticleFrontiers in medicine2026

Investigating the impact of dual-chain coupling on new quality productive forces in leading traditional Chinese medicine enterprises.

Zhiguang Li, Wenwu Zhao, Fan Zhang, Ruijin Xie

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhiguang LiSchool of Economics and Management, Anhui University of Chinese Medicine, Hefei, China.
Wenwu ZhaoSchool of Economics and Management, Anhui University of Chinese Medicine, Hefei, China.
Fan ZhangSchool of Economics and Management, Anhui University of Chinese Medicine, Hefei, China.
Ruijin XieSchool of Economics and Management, Anhui University of Chinese Medicine, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: New quality productive forces are increasingly recognized as essential drivers of high-quality development in health-related industries. In the context of TCM, the synergy between talent chain and supply chain may play a pivotal role in shaping firms' capacity to contribute to public health goals. Purpose: This study investigates the impact of talent-supply chain synergy on new quality productive forces in leading TCM manufacturing enterprises, and examines the mediating role of innovation investment. It also explores how regional institutional contexts, such as TCM healthcare infrastructure, education systems, and policy environments, moderate this relationship. Methods: The study utilizes panel data from 75 publicly listed TCM manufacturers in China from 2015 to 2023. A stepwise regression is conducted to assess the effects of talent-supply chain synergy on new quality productive forces and the mediating role of innovation investment. In addition, heterogeneity across regional institutional contexts, including TCM healthcare infrastructure, education systems, and policy environments, is to examine the effects of dual-chain coupling coordination vary under different contextual conditions. Findings: The results indicate that: (1) the coupled synergy between the talent chain and the supply chain significantly enhances firms' new quality productive forces; (2) innovation investment plays a critical mediating role in linking dual-chain synergy to the development of new quality productive forces; and (3) the positive effects of dual-chain synergy are more pronounced in regions with stronger TCM healthcare infrastructure, more developed TCM education systems, and more favorable policy environments. Originality/value: This study offers theoretical insights into how dual-chain coordination contributes to the advancement of new quality productive forces and provides practical guidance for TCM enterprises in enhancing innovation investment and optimizing their alignment with regional institutional contexts.

Indexed as

dual-chain synergyinnovation investmentnew quality productive forcespublic healthsupply chaintalent chaintraditional Chinese medicine

Identifiers

PMID42266963
PMCPMC13243264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.